Free for academic non-profit institutions. Other users need a Commercial license
This gene encodes a non-receptor tyrosine kinase belonging to the Tec kinase family. The protein contains a PH-like domain, which mediates membrane targeting by binding to phosphatidylinositol 3,4,5-triphosphate (PIP3), and a SH2 domain that binds to tyrosine-phosphorylated proteins and functions in signal transduction. The protein is implicated in several signal transduction pathways including the Stat pathway, and regulates differentiation and tumorigenicity of several types of cancer cells. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2016]
BMX (BMX Non-Receptor Tyrosine Kinase) is a Protein Coding gene. Diseases associated with BMX include Agammaglobulinemia, X-Linked and Wet Beriberi. Among its related pathways are Tyrosine Kinases / Adaptors and Apoptotic execution phase. Gene Ontology (GO) annotations related to this gene include transferase activity, transferring phosphorus-containing groups and protein tyrosine kinase activity. An important paralog of this gene is BTK.
GeneHancer (GH) Identifier | GH Type | GH Score |
GH Sources | Gene Association Score | Total Score | TSS distance (kb) | Number of Genes Away | Size (kb) | Transcription Factor Binding Sites |
Gene Targets |
---|---|---|---|---|---|---|---|---|---|---|
GH0XJ015499 | Promoter/Enhancer | 1.1 | EPDnew Ensembl ENCODE | 611.5 | +36.5 | 36459 | 2.2 | SCRT2 POLR2A ZBTB33 | BMX PIR RF00017-8173 ACE2 | |
GH0XJ015465 | Enhancer | 0.9 | Ensembl ENCODE | 600.7 | +1.1 | 1055 | 1.8 | BACH1 TCF12 IKZF2 TRIM22 ARID3A DPF2 RELB JUND BCL11A ARNT | BMX PIR PIR-FIGF | |
GH0XJ015507 | Promoter | 0.4 | EPDnew | 600.3 | +43.0 | 43045 | 0.1 | CTCF | BMX ACE2 GS1-594A7.3 PIR RF00017-8173 | |
GH0XJ015343 | Enhancer | 0.9 | Ensembl ENCODE | 12.8 | -120.8 | -120807 | 1.1 | CREB1 ZNF629 FOXA1 REST ATF7 SCRT2 CEBPB ZBTB20 SP1 BRCA1 | BMX PIR ASB11 PIGA piR-41405-154 VEGFD | |
GH0XJ015384 | Promoter/Enhancer | 1 | EPDnew Ensembl | 11.4 | -79.6 | -79645 | 0.8 | SP1 CEBPA CEBPB YY1 NR2F2 NR2F1 RAD21 ZFP91 NR2F6 HNF4A | VEGFD BMX PIR RF01045-154 PIR-FIGF |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000166 | nucleotide binding | IEA | -- |
GO:0004672 | protein kinase activity | IEA | -- |
GO:0004713 | protein tyrosine kinase activity | TAS | 7970727 |
GO:0004715 | non-membrane spanning protein tyrosine kinase activity | TAS | -- |
GO:0005515 | protein binding | IPI | 10688651 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005654 | nucleoplasm | IDA | -- |
GO:0005737 | cytoplasm | IEA | -- |
GO:0005829 | cytosol | TAS | -- |
GO:0005886 | plasma membrane | IDA | -- |
GO:0032587 | ruffle membrane | IDA | 11331870 |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | Apoptotic execution phase |
.31
|
|
2 | Metabolism |
.40
|
|
3 | PI Metabolism |
.63
|
|
4 | NF-kappaB Signaling | ||
5 | Tyrosine Kinases / Adaptors |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0002250 | adaptive immune response | IBA | 21873635 |
GO:0006468 | protein phosphorylation | TAS | 7970727 |
GO:0006661 | phosphatidylinositol biosynthetic process | TAS | -- |
GO:0006915 | apoptotic process | IEA | -- |
GO:0007155 | cell adhesion | IEA | -- |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
fostamatinib | Approved, Investigational | Pharma | Target, inhibitor | Kinase Inhibitors | 0 | |
Zanubrutinib | Approved, Investigational | Pharma | Target, inhibitor | 33 | ||
ATP | Investigational | Nutra | Agonist, Activator, Partial agonist, Antagonist, Full agonist, Gating inhibitor, Pore Blocker, Potentiation | 0 | ||
BMX-IN-1 | Pharma | BMX (also termed ETK) kinase inhibitor | 0 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs | |
---|---|---|---|---|---|---|
ADP |
|
Agonist, Full agonist, Partial agonist, Gating inhibitor, Antagonist | 58-64-0 |
|
Compound | Action | Cas Number |
---|---|---|
BMX-IN-1 | BMX (also termed ETK) kinase inhibitor | 1431525-23-3 |
This gene was present in the common ancestor of animals.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | BMX 30 31 |
|
OneToOne | |
Cow (Bos Taurus) |
Mammalia | BMX 30 31 |
|
OneToOne | |
Dog (Canis familiaris) |
Mammalia | BMX 30 31 |
|
OneToOne | |
Mouse (Mus musculus) |
Mammalia | Bmx 30 17 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Bmx 30 |
|
||
Oppossum (Monodelphis domestica) |
Mammalia | BMX 31 |
|
OneToOne | |
Platypus (Ornithorhynchus anatinus) |
Mammalia | BMX 31 |
|
OneToOne | |
Chicken (Gallus gallus) |
Aves | BMX 30 31 |
|
OneToOne | |
Lizard (Anolis carolinensis) |
Reptilia | BMX 31 |
|
OneToOne | |
Fruit Fly (Drosophila melanogaster) |
Insecta | Btk29A 31 32 |
|
OneToMany | |
Worm (Caenorhabditis elegans) |
Secernentea | T14E8.1a 32 |
|
|
|
T14E8.1b 32 |
|
|
|||
F26E4.5 32 |
|
|
|||
spe-8 32 |
|
|
|||
C25A8.5 32 |
|
|
|||
T25B9.4 32 |
|
|
|||
F22B3.8 32 |
|
|
|||
R05H5.4 32 |
|
|
|||
F23C8.7 32 |
|
|
|||
F59A3.8 32 |
|
|
|||
kin-24 32 |
|
|
|||
Sea Squirt (Ciona savignyi) |
Ascidiacea | -- 31 |
|
ManyToMany |
SNP ID | Clinical significance and condition | Chr 0X pos | Variation | AA Info | Type |
---|---|---|---|---|---|
722714 | Benign: not provided | 15,542,189(+) | C/T | SYNONYMOUS_VARIANT | |
726139 | Benign: not provided | 15,511,457(+) | T/A | SYNONYMOUS_VARIANT | |
728813 | Benign: not provided | 15,522,476(+) | C/T | MISSENSE_VARIANT | |
739305 | Benign: not provided | 15,549,831(+) | G/C | INTRON_VARIANT | |
rs1029888196 | A lung large cell carcinoma sample | p.Arg670Trp |
Disorder | Aliases | PubMed IDs |
---|---|---|
agammaglobulinemia, x-linked |
|
|
wet beriberi |
|
|
agammaglobulinemia |
|
|
cardiomyopathy, dilated, 1gg |
|
|
beriberi |
|
|